Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Employees

Regeneron Pharmaceuticals had 15,410 employees as of December 31, 2025. The number of employees increased by 304 or 2.01% compared to the previous year.

• Employees: 15,410
• Change (1Y): 304
• Growth (1Y): 2.01%
• Revenue / Employee: $968,177
• Profits / Employee: $287,047
• Market Cap: 64.65B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	15,410	304	2.01%
Dec 31, 2024	15,106	1,656	12.31%
Dec 31, 2023	13,450	1,599	13.49%
Dec 31, 2022	11,851	1,483	14.30%
Dec 31, 2021	10,368	1,245	13.65%
Dec 31, 2020	9,123	1,023	12.63%
Dec 31, 2019	8,100	700	9.46%
Dec 31, 2018	7,400	1,200	19.35%
Dec 31, 2017	6,200	800	14.81%
Dec 31, 2016	5,400	1,100	25.58%
Dec 31, 2015	4,300	1,375	47.01%
Dec 31, 2014	2,925	585	25.00%
Dec 31, 2013	2,340	390	20.00%
Dec 31, 2012	1,950	246	14.44%
Dec 31, 2011	1,704	309	22.15%
Dec 31, 2010	1,395	366	35.57%
Dec 31, 2009	1,029	110	11.97%
Dec 31, 2008	919	237	34.75%
Dec 31, 2007	682	109	19.02%
Dec 31, 2006	573	-15	-2.55%
Dec 31, 2005	588	-142	-19.45%
Dec 31, 2004	730	86	13.35%
Dec 31, 2003	644	-25	-3.74%
Dec 31, 2002	669	94	16.35%
Dec 31, 2001	575	84	17.11%
Dec 31, 2000	491	54	12.36%
Dec 31, 1999	437	66	17.79%
Dec 31, 1998	371	101	37.41%
Dec 31, 1997	270	27	11.11%
Dec 31, 1996	243	-	-

Data Source: Official company filings Last updated: Dec 31, 2025

The employees data for this stock was gathered manually by the Stock Analysis team based on SEC filings and investor relations materials.

Update frequency:

Yearly

Last checked:

Jun 5, 2026

Data Sources Report a data error